Prognostic factors in advanced multiple myeloma patients treated with the association of bortezomib, melphalan, prednisone and thalidomide (VMPT)

被引：0
|
作者：
Palumbo, A. [1 ]
Gay, F. [1 ]
Ambrosini, M. T. [1 ]
Benevolo, G. [2 ]
Pregno, F. [2 ]
Pescosta, N.
Callea, V [3 ]
Cangialosi, C. [4 ]
Caravita, T. [5 ]
Morabito, F. [6 ]
Musto, P. [7 ]
Larocca, A. [1 ]
Caltagirone, S. [1 ]
Avonto, I [1 ]
Cavallo, F. [1 ]
Boccadoro, M. [1 ]
机构：
[1] Univ Turin, Az Osp S Giovanni Battista, Div Ematol, Turin, Italy
[2] Azienda Osped San Giovanni Battista, Turin, Italy
[3] Osped Riuniti Bergamo, Div Ematol, Reggio Di Calabria, Italy
[4] Azienda Osped Cervello, Div Ematol Trapianto Midollo Osseo, Palermo, Italy
[5] Univ Roma Tor Vergata, Osped San Eugenio, Cattedra & Div Ematol, Rome, Italy
[6] Azienda Osped Cosenza, UOC Ematol, Cosenza, Italy
[7] UOC Ematol Trapianto Cellule Staminali, CROB, Naples, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：140 / 140
页数：1
相关论文
共 50 条
  • [11] Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial
    Mateos, Maria-Victoria
    Oriol, Albert
    Martinez-Lopez, Joaquin
    Gutierrez, Norma
    Teruel, Ana-Isabel
    de Paz, Raquel
    Garcia-Larana, Jose
    Bengoechea, Enrique
    Martin, Alejandro
    Diaz Mediavilla, Joaquin
    Palomera, Luis
    de Arriba, Felipe
    Gonzalez, Yolanda
    Hernandez, Jose-Mariano
    Sureda, Ana
    Bello, Jose-Luis
    Bargay, Joan
    Penalver, Francisco-Javier
    Ribera, Jose-Maria
    Martin-Mateos, Maria-Luisa
    Garcia-Sanz, Ramon
    Cibeira, Maria-Teresa
    Martin Ramos, Maria-Luisa
    Vidriales, Maria-Belen
    Paiva, Bruno
    Montalban, Maria-Angeles
    Lahuerta, Juan-Jose
    Blade, Joan
    San Miguel, Jesus-Fernando
    LANCET ONCOLOGY, 2010, 11 (10): : 934 - 941
  • [12] Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: A Randomized Controlled Trial
    Palumbo, Antonio
    Bringhen, Sara
    Rossi, Davide
    Cavalli, Maide
    Larocca, Alessandra
    Ria, Roberto
    Offidani, Massimo
    Patriarca, Francesca
    Nozzoli, Chiara
    Guglielmelli, Tommasina
    Benevolo, Giulia
    Callea, Vincenzo
    Baldini, Luca
    Morabito, Fortunato
    Grasso, Mariella
    Leonardi, Giovanna
    Rizzo, Manuela
    Falcone, Antonietta Pia
    Gottardi, Daniela
    Montefusco, Vittorio
    Musto, Pellegrino
    Petrucci, Maria Teresa
    Ciccone, Giovannino
    Boccadoro, Mario
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (34) : 5101 - 5109
  • [13] Melphalan, prednisone, thalidomide and defibrotide in advanced myeloma
    Palumbo, A.
    Gay, F.
    Rus, C.
    Pregno, P.
    Larocca, A.
    Bringhen, S.
    Magarotto, V.
    D'Agostino, F.
    Iacobelli, M.
    Gaidano, G.
    Mitsiades, C.
    Richardson, P. G.
    Anderson, K. C.
    Boccadoro, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 169 - 169
  • [14] Efficacy of Lenalidomide in Patients with Multiple Myeloma Previously Treated by Melphalan-Prednisone and Thalidomide
    Michel, Jessica
    Revuz, Sabine
    Tardy, Stephanie
    Fouquet, Guillemette
    Roussel, Murielle
    Balasanu, Oana
    Bologna, Serge
    Bonmati, Caroline
    Perrot, Aurore
    Ranta, Dana
    Feugier, Pierre
    Attal, Michel
    Leleu, Xavier
    Facon, Thierry
    Hulin, Cyrille
    BLOOD, 2012, 120 (21)
  • [15] Bortezomib plus Melphalan and Prednisone for Multiple Myeloma
    Avvisati, Giuseppe
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (24): : 2613 - 2613
  • [16] Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma
    Zweegman, Sonja
    van der Holt, Bronno
    Mellqvist, Ulf-Henrik
    Salomo, Morten
    Bos, Gerard M. J.
    Levin, Mark-David
    Visser-Wisselaar, Heleen
    Hansson, Markus
    van der Velden, Annette W. G.
    Deenik, Wendy
    Gruber, Astrid
    Coenen, Juleon L. L. M.
    Plesner, Torben
    Klein, Saskia K.
    Tanis, Bea C.
    Szatkowski, Damian L.
    Brouwer, Rolf E.
    Westerman, Matthijs
    Leys, M. B. L.
    Sinnige, Harm A. M.
    Haukas, Einar
    van der Hem, Klaas G.
    Durian, Marc F.
    Mattijssen, E. J. M.
    van de Donk, Niels W. C. J.
    Stevens-Kroef, Marian J. P. L.
    Sonneveld, Pieter
    Waage, Anders
    BLOOD, 2016, 127 (09) : 1109 - 1116
  • [17] Indirect Comparison of the Efficacy of Melphalan-Prednisone-Bortezomib Relative to Melphalan-Prednisone-Thalidomide and Melphalan-Prednisone for the First Line Treatment of Multiple Myeloma
    Yeh, Yating
    Chambers, James
    Gaugris, Sabine
    Jansen, Jeroen
    BLOOD, 2008, 112 (11) : 825 - 825
  • [18] Bortezomib plus melphalan and prednisone (VMP) in elderly untreated patients with multiple myeloma:: Prognostic factors influencing time to progression
    Mateos, M.-V. M.
    Hernandez, J.-M.
    Hemandez, M.-T.
    Gutierrez, N.-C.
    Palomera, L.
    Fuertes, M.
    Garcia, P.
    Lahuerta, J. J.
    De la Rubia, J.
    Terol, M. J.
    Sureda, A.
    Bargay, J.
    Ribas, P.
    De Arriba, E.
    Alegre, A.
    Oriol, A.
    Carrera, D.
    Garcia-Larana, J.
    Garcia-Sanz, R.
    Bladé, J.
    Prosper, F.
    Esseltine, D.-L.
    Van de Velde, H.
    San-Miguel, J.-F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 148 - 149
  • [19] Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma
    Waage, Anders
    Gimsing, Peter
    Fayers, Peter
    Abildgaard, Niels
    Ahlberg, Lucia
    Bjorkstrand, Bo
    Carlson, Kristina
    Dahl, Inger Marie
    Forsberg, Karin
    Gulbrandsen, Nina
    Haukas, Einar
    Hjertner, Oyvind
    Hjorth, Martin
    Karlsson, Torbjorn
    Knudsen, Lene Meldgaard
    Nielsen, Johan Lanng
    Linder, Olle
    Mellqvist, Ulf-Henrik
    Nesthus, Ingerid
    Rolke, Jurgen
    Strandberg, Maria
    Sorbo, Jon Hjalmar
    Wisloff, Finn
    Juliusson, Gunnar
    Turesson, Ingemar
    BLOOD, 2010, 116 (09) : 1405 - 1412
  • [20] Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: Updated Follow-Up and Improved Survival
    Palumbo, Antonio
    Bringhen, Sara
    Larocca, Alessandra
    Rossi, Davide
    Di Raimondo, Francesco
    Magarotto, Valeria
    Patriarca, Francesca
    Levi, Anna
    Benevolo, Giulia
    Vincelli, Iolanda Donatella
    Grasso, Mariella
    Franceschini, Luca
    Gottardi, Daniela
    Zambello, Renato
    Montefusco, Vittorio
    Falcone, Antonietta Pia
    Omede, Paola
    Marasca, Roberto
    Morabito, Fortunato
    Mina, Roberto
    Guglielmelli, Tommasina
    Nozzoli, Chiara
    Passera, Roberto
    Gaidano, Gianluca
    Offidani, Massimo
    Ria, Roberto
    Petrucci, Maria Teresa
    Musto, Pellegrino
    Boccadoro, Mario
    Cavo, Michele
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (07) : 634 - +
12345